Equity Research Medical Devices

Should You Buy Ludwig Enterprises, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Ludwig Enterprises, Inc. (LUDG) scores 3.7/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $0.01, our multi-model valuation analyzes whether the market has already discounted these weaknesses.

The short answer: 1 of 1 CirclFi valuation models project upside for Ludwig Enterprises, Inc. (LUDG) at $0.01 — the model consensus leans bullish, with a Quality Score of 3.7/10 and Value-Trap risk of 27/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 3.7/10 — Weak — below-average fundamentals
  • Value Trap Risk: 27/100 — Low — manageable risk
  • Fair Value Range: $0.01 – $0.01 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

3.7 /10

Weak — below-average fundamentals

Value Trap Risk

27 /100
Low

Low — manageable risk

Model Consensus

1 /13
Active Models

Avg. confidence: 30%

What Is the Investment Case for Ludwig Enterprises, Inc. (LUDG) in 2026?

What Is the Bull Case vs the Bear Case for Ludwig Enterprises, Inc. (LUDG)?

Bull case versus bear case for Ludwig Enterprises, Inc. (LUDG) at $0.01, derived from 1 active CirclFi valuation models on 2026-10-07.
Bull case — $0.01 target (+0.8%) Bear case
Industry tailwind: therapeutic area leadership could provide meaningful support for Ludwig Enterprises, Inc.'s revenue and margin trajectory in the Medical Devices space. No active model flags significant downside for LUDG. The low Value Trap score paints a constructive picture.

How Does LUDG Compare to Its Medical Devices Peers?

ALMR Alamar Biosciences,
3.8
STME STIMCELL ENERGETICS
3.7
MOBI Mobia Medical, Inc.
3.8
ODYY Odyssey Health, Inc.
3.7
PFSA Profusa, Inc.
4.0
LMRI Lumexa Imaging Holdi
3.5
GEHC GE HealthCare Techno
7.9
TMCI Treace Medical Conce
6.5

Valuation data pages: ALMR · STME · MOBI · ODYY · PFSA · LMRI · GEHC · TMCI · BMRA · IRMD · PODD

See full Medical Devices rankings →

Which Other Stocks Score Like LUDG on Quality?

Closest companies to LUDG’s Quality of Company score of 3.7/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on LUDG?

Spread

0%

Fair Value Range

$0.01 – $0.01

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

PWERM

$0.01 (+0.8%)

Most Bearish

PWERM

$0.01 (+0.8%)

What Are the Biggest Risks of Buying LUDG Stock?

Weak Fundamentals

QOC 3.7/10 signals below-average quality.

Macro/Sector Risk

Medical Devices headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View LUDG Data Page →

So Is Ludwig Enterprises, Inc. (LUDG) Worth Buying in 2026?

Ludwig Enterprises, Inc. at $0.01 is a genuine coin-flip in our framework. The 0–0 bull-bear split across 1 models, +0.0% model spread, and median fair value of $0.01 (+0.8% vs price) argue for a watchlist position rather than a high-conviction bet. Quality at 3.7/10 adds additional caution to the mix.

These are quantitative model outputs, not investment recommendations. Ludwig Enterprises, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About LUDG Stock?

Should I buy LUDG stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for LUDG at $0.01. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 3.7/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Ludwig Enterprises, Inc.?

Key risks include: a below-average Quality Score of 3.7/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.

How does LUDG compare to its competitors?

Among Medical Devices peers, LUDG holds a Quality Score of 3.7/10. Comparable companies include ALMR (QOC 3.8), STME (QOC 3.7), MOBI (QOC 3.8). The relative ranking helps investors identify whether LUDG offers better fundamental quality than alternatives in the same sector.

Is LUDG a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. LUDG's Quality Score of 3.7/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy LUDG at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $0.01 to $0.01. At $0.01, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for LUDG.

View LUDG Data Page Full Terminal — $60/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →